- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00737321
Mechanisms Regulating Wound Vascularization
November 18, 2021 updated by: Gayle Gordillo
This pilot study is designed to assess the impact of ischemia/ diminished wound vascularization and stress on wound healing by comparing patterns of gene expression in specific cell types critical to wound healing biology, e.g.
macrophages or endothelial cells.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Chronic wounds affect approximately 2% of the U.S. population at any given time.
Animal models can not simulate the complex set of pre-existing conditions in each individual that results in failed wound healing.
Therefore, human subjects must be used to obtain valid data.
Adequate wound vascularization that permits blood vessels to deliver oxygen to the wound is a requirement for wound healing to occur.
This protocol will attempt to gain greater understanding of the mechanisms of chronic wounds through 3 specific aims: 1) identify the angiogenic mechanisms in wound site macrophages, which are required for healing, 2) determine the impact of stress and glucocorticoid resistance on endothelial cell and macrophage biology and ultimately wound healing outcomes, 3) identify patterns of gene expression in wound endothelial cells that are found in healing versus non-healing wounds.
This data will be correlated with the wound oxygenation status to determine the impact of wound vascularization on the observed biological responses.
Study Type
Observational
Enrollment (Actual)
36
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- OSU East Wound Care Center
-
Columbus, Ohio, United States, 43221
- OSU Comprehensive Wound Care Center Morehouse
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients (n=80)including controlled group will be recruited from the OSU outpatient wound care center located at Morehouse plaza and OSU East, OSU plastic surgery, OSU diabetic clinics.
Description
Inclusion Criteria:
- Age 18-69 years
- ischemic wound group
- non-ischemic wound group
- diabetes with good glycemic control
- lower extremity wound
Exclusion Criteria:
- Age greater ≥ 70 years
- End stage renal disease
- Unable to provide informed consent
- Pregnant women
- Therapeutically anticoagulated
- Prisoners
- Periwound TcOM < 25mmHg
- Spinal cord injury
- Taking immunosuppressive medications
- Individuals with current diagnosis of a major psychiatric illness (e.g.schizophrenia,psychosis)
- Severe protein malnutrition- pre-albumin < 10 mg/dl or albumin < 2 g/dl
- Diabetes with poor glucose control-defined as hgb A1c > 8.4%
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
2- Diabetics without wound (s)
These group of subject will be control arm, included who have good glycemic control diabetic with HbA1c 8.4 or lower and also without any open wounds.
Samples will be collected.
|
wound tissue biopsy, blood samples, saliva collection and wound VAC sponge (if applicable).
|
1-Subjects with diabetes with wound
This group of subjects will have wound and come for couple of follow up visits for saliva collection, biopsy collection and blood draw.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in Gene Expression Profile in Healing versus Non-healing Wounds
Time Frame: 12 weeks
|
Wound tissue biopsies, saliva, serum samples and wound sponges will be obtained at an initial time point, at the midpoint of the study and near the end of wound closure over a 12 week window.
If the wound closes quickly, i.e. less than 4 weeks then only 2 biopsies will be obtained.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2008
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
December 1, 2018
Study Registration Dates
First Submitted
August 15, 2008
First Submitted That Met QC Criteria
August 18, 2008
First Posted (Estimate)
August 19, 2008
Study Record Updates
Last Update Posted (Actual)
December 1, 2021
Last Update Submitted That Met QC Criteria
November 18, 2021
Last Verified
November 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008H0051
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds and Injuries
-
3MWithdrawn
-
Centre Hospitalier Universitaire de NīmesCompletedWounds and Injuries, Hands | Wounds and Injuries, Wrists | Wounds and Injuries, Feet | Wounds and Injuries, AnklesFrance
-
Samsung Medical CenterCompletedNeedle Stick InjuriesKorea, Republic of
-
Assaf-Harofeh Medical CenterUnknownInjuries and Wounds
-
Karolinska InstitutetCompletedWounds and Injuries | Blast Injuries | War-Related Injuries | Gunshot WoundSweden
-
Hospital Universiti Sains MalaysiaActive, not recruiting
-
Medical University of South CarolinaCompletedNeedlestick InjuriesUnited States
-
Karolinska InstitutetMedecins Sans Frontieres, NetherlandsCompletedWounds and Injuries | Leg Injuries | Soft Tissue Injuries | Wound Infection | Arm Injuries | Wounds, Penetrating | Wounds, Gunshot | War-Related InjuriesJordan
-
HTL-Strefa S.A.CompletedAccident InjuryUnited States
Clinical Trials on Samples will be collected
-
Atatürk UniversityCompletedCardiovascular Diseases | Periodontal DiseasesTurkey
-
Professor Michael BourkeCompleted
-
Institut Claudius RegaudCompleted
-
Institut Claudius RegaudFondation ARCRecruiting
-
Institut Claudius RegaudRecruitingCervical Cancer | Head and Neck Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Anal Cancer | Cervical Intraepithelial Neoplasia 3 | Glioblastoma Multiforme of Brain StemFrance
-
Atatürk UniversityRecruitingObesity | Diabetes Mellitus | PeriodontitisTurkey
-
University Hospital, BordeauxCompleted
-
Hospices Civils de LyonJanssen, LPCompleted
-
Institut Claudius RegaudRecruiting
-
Zhejiang Cancer HospitalRecruitingCholangiocarcinoma | Biliary Tract TumorChina